MARIMED INC. Annual Report - Summary

This summary outlines key information from MARIMED INC.'s annual report (Form 10-K) for the fiscal year ended December 31, 2025. Incorporated in Delaware, MARIMED INC. regularly files reports with the SEC. Its Common Stock carries a par value of $0.001 per share, and the company does not qualify as a "well-known seasoned issuer."

A major development during the year centered on a federal tax lien and a subsequent amendment to a significant construction loan. MARIMED INC. guarantees obligations for related entities, including Mari Holdings MD LLC and Kind Therapeutics USA, LLC, which operate in real estate and cannabis.

Business Overview

MARIMED INC. engages in real estate development, indicated by its construction loan activities and references to a "rent roll." Through subsidiaries like Kind Therapeutics USA, LLC, the company also appears to operate in the cannabis industry.

Financial Performance

A significant financial event impacted the company's health: on June 5, 2025, authorities filed a federal tax lien against MARIMED INC. for $6,286,443.72. This lien relates to its 2023 income taxes, plus additional penalties and interest.

Risk Factors

Key risks include:

• Tax Liability: The unresolved $6.28 million federal tax lien for 2023 income taxes poses a significant financial risk. The outcome of the company's challenge to this lien remains uncertain.
• Cash Flow Strain: Mandatory $100,000 monthly deposits into a blocked reserve account, starting January 23, 2026, will directly reduce available cash flow. This could impact other investments or operational needs.
• Default Risk: Failing to make these monthly reserve payments within three business days of the due date now constitutes an "Event of Default" on the company's substantial $58.7 million construction loan. Such a default could trigger serious consequences, including the lender demanding immediate repayment of the entire loan.
• Lender Confidence: Needham Bank's requirement for a loan amendment and the establishment of a reserve account indicates the lender perceives increased risk due to the federal tax lien.

Management Discussion (MD&A Highlights)

The $6.28 million federal tax lien for 2023 income taxes was the most significant event affecting the company's financial condition and liquidity this year. Although MARIMED INC. is "diligently challenging" this lien, its presence required an amendment to the existing $58,695,000.00 construction loan with Needham Bank.

Dated December 31, 2025, this amendment mandates that MARIMED INC. and its associated borrowers deposit $100,000.00 monthly into a special, non-interest-bearing reserve account. These deposits begin January 23, 2026, and will continue until the account covers the full amount of the disputed tax lien. While this measure aims to mitigate the lender's risk, it will directly impact the company's liquidity and capital resources.

Financial Health

MARIMED INC. guarantees a substantial $58.7 million construction loan. The $6.28 million federal tax lien represents a significant liability. Starting in January 2026, the new requirement to deposit $100,000 monthly into a blocked reserve account will directly reduce the company's operational cash flow and liquidity. This means less cash will be available for other business needs until the tax lien is resolved.

Future Outlook

A significant part of the company's immediate future will involve managing and resolving the $6.28 million federal tax lien and consistently funding the mandated reserve account. This will be a primary financial and operational focus for the company starting in 2026.